Posted by Michael Wonder on 18 Mar 2021
UK approval for Daiichi Sankyo’s cholesterol lowering treatments
18 March 2021 - Daiichi Sankyo’s cholesterol-lowering drugs Nilemdo and Nustendi have been approved by the UK National Institute for Health and Care Excellence for use on the NHS.
Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) have been recommended for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia (heterozygous familial and non-familial).
